Protocol for the insight study: A randomised controlled trial of singledose tocilizumab in patients with depression and low-grade inflammation

10.1136/bmjopen-2018-025333

Saved in:
Bibliographic Details
Main Authors: Khandaker, GM, Oltean, BP, Kaser, M, Dibben, CRM, Ramana, R, Jadon, DR, Dantzer, R, Coles, AJ, Lewis, G, Jones, PB
Other Authors: DEPT OF PSYCHOLOGICAL MEDICINE
Format: Article
Published: 2023
Subjects:
Online Access:https://scholarbank.nus.edu.sg/handle/10635/246034
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: National University of Singapore
id sg-nus-scholar.10635-246034
record_format dspace
spelling sg-nus-scholar.10635-2460342023-11-17T08:18:52Z Protocol for the insight study: A randomised controlled trial of singledose tocilizumab in patients with depression and low-grade inflammation Khandaker, GM Oltean, BP Kaser, M Dibben, CRM Ramana, R Jadon, DR Dantzer, R Coles, AJ Lewis, G Jones, PB DEPT OF PSYCHOLOGICAL MEDICINE clinical trials Antibodies, Monoclonal, Humanized Biomarkers C-Reactive Protein Cognition Depressive Disorder Double-Blind Method Humans Inflammation Infusions, Intravenous Proof of Concept Study Psychiatric Status Rating Scales Randomized Controlled Trials as Topic Receptors, Interleukin-6 Treatment Outcome 10.1136/bmjopen-2018-025333 BMJ Open 8 9 e025333- 2023-11-17T08:04:16Z 2023-11-17T08:04:16Z 2018-01-01 2023-11-17T05:20:18Z Article Khandaker, GM, Oltean, BP, Kaser, M, Dibben, CRM, Ramana, R, Jadon, DR, Dantzer, R, Coles, AJ, Lewis, G, Jones, PB (2018-01-01). Protocol for the insight study: A randomised controlled trial of singledose tocilizumab in patients with depression and low-grade inflammation. BMJ Open 8 (9) : e025333-. ScholarBank@NUS Repository. https://doi.org/10.1136/bmjopen-2018-025333 2044-6055 https://scholarbank.nus.edu.sg/handle/10635/246034 Elements
institution National University of Singapore
building NUS Library
continent Asia
country Singapore
Singapore
content_provider NUS Library
collection ScholarBank@NUS
topic clinical trials
Antibodies, Monoclonal, Humanized
Biomarkers
C-Reactive Protein
Cognition
Depressive Disorder
Double-Blind Method
Humans
Inflammation
Infusions, Intravenous
Proof of Concept Study
Psychiatric Status Rating Scales
Randomized Controlled Trials as Topic
Receptors, Interleukin-6
Treatment Outcome
spellingShingle clinical trials
Antibodies, Monoclonal, Humanized
Biomarkers
C-Reactive Protein
Cognition
Depressive Disorder
Double-Blind Method
Humans
Inflammation
Infusions, Intravenous
Proof of Concept Study
Psychiatric Status Rating Scales
Randomized Controlled Trials as Topic
Receptors, Interleukin-6
Treatment Outcome
Khandaker, GM
Oltean, BP
Kaser, M
Dibben, CRM
Ramana, R
Jadon, DR
Dantzer, R
Coles, AJ
Lewis, G
Jones, PB
Protocol for the insight study: A randomised controlled trial of singledose tocilizumab in patients with depression and low-grade inflammation
description 10.1136/bmjopen-2018-025333
author2 DEPT OF PSYCHOLOGICAL MEDICINE
author_facet DEPT OF PSYCHOLOGICAL MEDICINE
Khandaker, GM
Oltean, BP
Kaser, M
Dibben, CRM
Ramana, R
Jadon, DR
Dantzer, R
Coles, AJ
Lewis, G
Jones, PB
format Article
author Khandaker, GM
Oltean, BP
Kaser, M
Dibben, CRM
Ramana, R
Jadon, DR
Dantzer, R
Coles, AJ
Lewis, G
Jones, PB
author_sort Khandaker, GM
title Protocol for the insight study: A randomised controlled trial of singledose tocilizumab in patients with depression and low-grade inflammation
title_short Protocol for the insight study: A randomised controlled trial of singledose tocilizumab in patients with depression and low-grade inflammation
title_full Protocol for the insight study: A randomised controlled trial of singledose tocilizumab in patients with depression and low-grade inflammation
title_fullStr Protocol for the insight study: A randomised controlled trial of singledose tocilizumab in patients with depression and low-grade inflammation
title_full_unstemmed Protocol for the insight study: A randomised controlled trial of singledose tocilizumab in patients with depression and low-grade inflammation
title_sort protocol for the insight study: a randomised controlled trial of singledose tocilizumab in patients with depression and low-grade inflammation
publishDate 2023
url https://scholarbank.nus.edu.sg/handle/10635/246034
_version_ 1783955468184453120